Health and Fitness Health and Fitness
Fri, March 8, 2013
[ Fri, Mar 08th 2013 ] - Market Wire
OrbusNeich File Patent Infringement Lawsuit Against Boston Scientific in Ireland
Thu, March 7, 2013
[ Thu, Mar 07th 2013 ] - Market Wire
Galapagos reports record revenues in 2012, increasing momentum in clinical pipeline
[ Thu, Mar 07th 2013 ] - Market Wire
Galapagos and Roche conclude strategic alliance
[ Thu, Mar 07th 2013 ] - Market Wire
Cornerstone Therapeutics to Host Fourth Quarter and Full Year 2012 Conference Call
[ Thu, Mar 07th 2013 ] - Market Wire
InspireMD Files Amended Registration Statement for Proposed Public Offering of Common Stock
[ Thu, Mar 07th 2013 ] - Market Wire
Stem Cell Therapeutics Announces Offering of Up to $3.5 Million of Units
[ Thu, Mar 07th 2013 ] - Market Wire
Corcept Therapeutics Announces Fourth Quarter and Full Year 2012 Financial Results
[ Thu, Mar 07th 2013 ] - Market Wire
Pharmacyclics, Inc. Announces Proposed Public Offering of Common Stock
[ Thu, Mar 07th 2013 ] - Market Wire
Masimo to Present at 25th Annual ROTH Conference
[ Thu, Mar 07th 2013 ] - Market Wire
Pre-Employment Drug Test Positives Increase More .. Data from Quest Diagnostics Drug Testing Indexa"
[ Thu, Mar 07th 2013 ] - Market Wire
West to Present at Barclays Conference
[ Thu, Mar 07th 2013 ] - Market Wire
Brookdale to Present at Barclays Global Healthcare Conference on March 12
[ Thu, Mar 07th 2013 ] - Market Wire
Vivakor Eliminates Convertible Debt
[ Thu, Mar 07th 2013 ] - Market Wire
Daxor Corporation Announces the Sale of a BVA-100 .. ner Good Samaritan Medical Center of Phoenix, Ari
[ Thu, Mar 07th 2013 ] - Market Wire
Orexigen Therapeutics to Host Full Year and Fourt .. 012 Financial Results Conference Call and Webcast
[ Thu, Mar 07th 2013 ] - Market Wire
Completion Expected To Be Faster Or More Efficient Than Relevant Comparison Trials
[ Thu, Mar 07th 2013 ] - Market Wire
Zynex Schedules 2012 Year End Earnings Release and Webcast
[ Thu, Mar 07th 2013 ] - Market Wire
LifeSci Advisors Initiates Coverage of Ampio Pharmaceuticals
[ Thu, Mar 07th 2013 ] - Market Wire
Milestone Scientific Schedules 2012 Year-End Earnings Conference Call
[ Thu, Mar 07th 2013 ] - Market Wire
Horizon Pharma Receives Marketing Authorization f .. Kingdom Medicines and Healthcare Products Regulat
[ Thu, Mar 07th 2013 ] - Market Wire
Uroplasty To Present At The 25th Annual ROTH Growth Stock Conference
[ Thu, Mar 07th 2013 ] - Market Wire
AcelRx Pharmaceuticals to Hold Fourth Quarter 201 .. lts Conference Call and Webcast on March 12, 2013
[ Thu, Mar 07th 2013 ] - Market Wire
Sarepta Therapeutics Announces Fourth Quarter and .. nancial Results and Recent Corporate Developments
Wed, March 6, 2013
[ Wed, Mar 06th 2013 ] - Market Wire
Basilea's Board proposes Martin Nicklasson to suc .. and recommends to shareholders that they do not s
[ Wed, Mar 06th 2013 ] - Market Wire
Fresenius Medical Care and DaVita Healthcare Partners Liable for GranuFlo and NaturaLyte Deaths
[ Wed, Mar 06th 2013 ] - Market Wire
Cadence Pharmaceuticals Announces Strategic Plan .. re and Supply of OFIRMEV (acetaminophen) Injectio
[ Wed, Mar 06th 2013 ] - Market Wire
Alexza to Report 2012 Year-End Financial Results on Tuesday, March 26, 2013
[ Wed, Mar 06th 2013 ] - Market Wire
Boston Scientific Updates PREVAIL Late Breaking Clinical Trials Presentation
[ Wed, Mar 06th 2013 ] - Market Wire
Discovery Labs to Report Fourth Quarter 2012 Resu .. Hold Conference Call on Wednesday, March 13, 2013
[ Wed, Mar 06th 2013 ] - Market Wire
PDL BioPharma to Hold Annual Meeting of Stockholders on May 21, 2013

PDL BioPharma to Hold Annual Meeting of Stockholders on May 21, 2013


Published on 2013-03-06 13:16:16 - Market Wire
  Print publication without navigation


PDL BioPharma to Hold Annual Meeting of Stockholders on May 21,... -- INCLINE VILLAGE, Nev., March 6, 2013 /PRNewswire/ --

[ ]

[ Download image ]

INCLINE VILLAGE, Nev., March 6, 2013 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: [ PDLI ]) today announced that the company will hold its annual meeting of stockholders on Tuesday, May 21, 2013, at 10:00 a.m. Pacific Time for all stockholders of record on March 28, 2013. The meeting will take place at the Hyatt Regency Hotel in Incline Village, Nevada.  

(Logo: [ http://photos.prnewswire.com/prnh/20110822/SF55808LOGO ])

About PDL BioPharma
PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. Today, PDL is focused on intellectual property asset management, investing in new income generating assets and maximizing value for its shareholders. For more information, please visit [ www.pdl.com ].

NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc.

 

SOURCE PDL BioPharma, Inc.



RELATED LINKS
[ http://www.pdl.com ]
Contributing Sources